Treatment satisfaction in patients with systemic lupus erythematosus

Treatment satisfaction in patients with systemic lupus erythematosus - Treatment satisfaction in SLE patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036207

Enrollment

Registered

2019-04-01

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic lupus erythematosus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients meet 1997 Update of the American College of Rheumatology revised criteria for classification of systemic lupus erythematosus

Exclusion criteria

Exclusion criteria: Patients without therapeutic agents

Design outcomes

Primary

Measure	Time frame
Comparison of treatment satisfaction between conventional immunosuppressive agents and newly approved drugs	—

Secondary

Measure	Time frame
Factors affecting treatment satisfaction	—

Countries

Japan

Contacts

Public ContactSusumu Nishiyama

Kurashiki Medical Center Rheumatic Disease Center

s_nishiyama@fkmc.or.jp086-422-2111

Outcome results